Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB18913InvestigationalSmall molecule
Cardiopet is under investigation in clinical trial NCT01826773 (Cardiopet as PET Imaging Agent to Assess Myocardial Perfusion and Fatty Acid Uptake in Known or Suspected CAD Subjects).
- Formula / weight
- C18H33FO2 · 299.461 g/mol (avg)
- Also known as
- (18f fcpha) · (18f)-fcpha · 2-((1s,2r)-2-(5-(fluoro-18f)tridecyl)cyclopropyl)acetic acid · Cyclopropaneacetic acid, 2-(5-(fluoro-18f)tridecyl)-, (1r,2s)-rel- · Trans-9(rs)-18f-fluoro-3,4(rs,rs)-methyleneheptadecanoic acid
Resolves to
Structure
InChIKey
DDTRZLZETKPBPQ-YWWFHXEUSA-NSMILESCCCCCCCCC([18F])CCCC[C@@H]1C[C@H]1CC(O)=OWhat you can answer from here — as of April 23, 2025
Which companies are running trials of Cardiopet, in which indications and phases, and which of those programs are still active?